Nuclea Biotechnologies, Inc. — Form D/A

Nuclea Biotechnologies, Inc. of PITTSFIELD, MA, a company, filed a Form D amendment with the SEC on 2010-11-01. $8.9M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (18)

NameRoleLocation
PAULA C EVANSExecutive OfficerPITTSFIELD, MA
William R HarmanDirectorNEW YORK, NY
Dennis K StoneDirectorHouston, TX
Richard R VietorDirectorSt. Louis, MO
Patrick J MuracaDirectorPittsfield, MA
Patrick J MuracaExecutive OfficerPittsfield, MA
Robert J PierceExecutive OfficerPittsfield, MA
Paula J EvansExecutive OfficerPittsfield, MA
Charles P StetsonDirectorPittsfield, MA
James W LewisDirectorJersey City, NJ
Richard W VietorDirectorPittsfield, MA
Richard R. VietorDirectorPittsfield, MA
Patrick J. MuracaDirectorPittsfield, MA
Patrick J. MuracaExecutive OfficerPittsfield, MA
Robert J. PierceExecutive OfficerPittsfield, MA
Paula J. EvansExecutive OfficerPittsfield, MA
Charles P. StetsonDirectorPittsfield, MA
William R. HarmanDirectorPittsfield, MA

Other filings by this issuer (9)

FiledFormOfferingSold
2013-02-20D$1.1M
2012-08-08D$5.0M
2012-05-03D$555K
2012-04-11D$1.9M
2011-08-18D$3.0M
2010-12-17D$4.0M$425K
2010-12-08D
2009-10-22D/A$3.4M
2009-06-24D$3.0M$1.0M

More